M
Mediplantex National Pharmaceutical JSC
VN:MED
Mediplantex National Pharmaceutical JSC
VN:MED
Price:
27 800
VND
-9.74%
Market Closed
Market Cap:
₫345B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Mediplantex National Pharmaceutical JSC
VN:MED
|
VN |
|
KEPCO Plant Service & Engineering Co Ltd
KRX:051600
|
KR |
|
Gold Standard Ventures Corp
TSX:GSV
|
CA |
|
A
|
Aerospace Nanhu Electronic Information Technology Co Ltd
SSE:688552
|
CN |
|
V
|
Vietnam Industrial Investments Ltd
ASX:VII
|
AU |
|
Teikoku Tsushin Kogyo Co Ltd
TSE:6763
|
JP |
|
G
|
Gold Hydrogen Ltd
ASX:GHY
|
AU |
Multiples-Based Value
The Multiples-Based Value for Mediplantex National Pharmaceutical JSC (MED) under the Base Case is hidden VND. Compared with the current market price of 27 800 VND, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MED Multiples-Based Value
LOCKED
Multiples Across Competitors
MED Competitors Multiples
Mediplantex National Pharmaceutical JSC Competitors
Mediplantex National Pharmaceutical JSC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| VN |
M
|
Mediplantex National Pharmaceutical JSC
VN:MED
|
345B VND | 0.9 | 22.6 | 12.3 | 16.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
878.2B USD | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
573B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232.5B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.3B USD | 4.6 | 16.2 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.4B CHF | 5.1 | 20.7 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.7 | 7.9 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.5B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
88.4B GBP | 2.7 | 15.6 | 8.4 | 10.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
